Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace <i>et al</i>.

Mathian, Alexis; Amoura, Zahir

Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al.

Mathian, Alexis; Amoura, Zahir.

Mathian A; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France alexis.mathian@aphp.fr.
Amoura Z; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Ann Rheum Dis ; 80(3): e36, 2021 03.

Article in English | MEDLINE | ID: covidwho-1909639

Subject(s)

COVID-19; Lupus Erythematosus, Systemic; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic/complications

Keywords

hydroxychloroquine; lupus erythematosus, systemic; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lupus Erythematosus, Systemic Topics: Long Covid Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-217910

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google